> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 2 Guidances on Developing Rhinitis Drug Products
- URL: https://www.fdaweb.com/2-guidances-on-developing-rhinitis-drug-products/
- Published: 2016-02-12T12:00:00.000Z
- Updated: 2026-09-15T02:35:31.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5134747

> FDA has posted two draft guidances on developing drug products for allergic and non-allergic rhinitis. The first guidance, “[Allergic Rhinitis: Developing Drug Products for Treatment](http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071293.pdf?ref=fdaweb.com),” addresses issues of trial design, effectiveness, and safety for new products being developed for treating seasonal allergic rhinitis and perennial allergic rhinitis. The second guidance, “[Nonallergic Rhinitis: Developing Drug Products for Treatment](http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM486105.pdf?ref=fdaweb.com),” discusses issues regarding the definition of a clinical phenotype, trial design, efficacy, and safety for such new drug products. it also covers development programs for products intended to treat vasomotor rhinitis.